Antifungal activity of redox-active benzaldehydes that target cellular antioxidation

Abstract

BackgroundDisruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy.MethodsBenzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus, A. flavus, A. terreus and Penicillium expansum, fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI).ResultsSeveral benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho-hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae (sod1Δ, sod2Δ, glr1Δ) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus (sakAΔ, mpkCΔ), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes.ConclusionsNatural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments.

Potentiation of Antibiofilm Activity of Amphotericin B by Superoxide Dismutase Inhibition

“…In addition, several reports document the possibility of enhancing the fungicidal activity of ROS-inducing antifungals by targeting the oxidative stress response system of fungi. For example, Kim and coworkers demonstrated that different redox-potent chemosensitizing agents like natural dihydroxybenzaldehydes, thymol, or salicylaldehyde could enhance the antifungal activity of different ROS-inducing antifungals [27–29]. One of their studies specifically demonstrates that chemically targeting the oxidative stress response system of fungi effectively augments antimycotic potency of AmB [28].…”

Thymol inhibits oral squamous cell carcinoma growth via mitochondria‐mediated apoptosis

“…The hydrophobic nature of thymol allows it to interact with lipids found in the cell and in mitochondrial membranes. In addition, thymol is a redox inhibitor that interferes with electron transport similar to vanilloids thereby inducing apoptosis . Accordingly, studies of thymol in B16 melanoma cells show that thymol cytotoxicity is reversible with the addition of vitamin C or vitamin E .…”

Antifungal Effect of Essential Oils against Fusarium Keratitis Isolates

“…Administration of novel antifungals or alternative adjunctive therapeutic agents (such as EOs) represents a possible solution [11]. EOs or their constituents may be used as monotherapy, but in combination with conventional drugs a more improved antifungal efficacy could be reached [12]. Beyond the improved antifungal activity, the dosage of antifungals and their side effects could be diminished and the emergence of resistance to them could be delayed [13].…”